Navigation Links
Alpha-blockers call for modification in cataract surgery

The risk of post-operative problems in cataract surgery is higher in patients who have taken alpha-blocker drugs like Flomax to treat an enlarged prostate.//

According to the 3 medical associations; The American Academy of Ophthalmology, the American Society of Cataract and Refractive Surgery and the American Urological Association, mentioning the use of drugs like Flomax (tamsulosin), Hytrin (terazosin), Cardura (doxazosin) or Uroxatral (alfuzosin) or any other drug categorized as an alpha-blocker can allow surgeons to alter their technique during the cataract surgery and avoid complications seen in such patients.

However, according to representatives from these medical associations said that there is no proof that these drugs can cause any long-term harm or vision loss. Patients with cataract need not stop the medications before having the surgery. It is just that the surgical procedure will be altered accordingly.

"You don't need to worry; you just need to inform your eye surgeon if you are currently taking, or have ever taken, Flomax or other alpha-blockers," said Dr. David F. Chang, clinical professor of ophthalmology at the University of California, San Francisco, School of Medicine.

Dr. Chang and Dr. John Campbell studied 1,600 patients who were using or had used Flomax or other alpha-blockers previously. These alpha-blockers seemed to restrain the muscle of the iris, from allowing the pupil to remain completely open during cataract surgery with conventional eye drops. This dilation is essential for the removal of the clouded, cataract-covered lens below the pupil and replacement with an artificial one.

Chang reported that the use of alpha-blocker may cause the pupil to suddenly constrict during surgery, causing the iris to relax. This condition was termed as "intraoperative floppy iris syndrome" by Chang and Campbell.

" This doesn't cause any eye disfigurement, but it can increase the risk of the su
'"/>




Page: 1 2 3

Related medicine news :

1. Prevention of cataracts
2. Artificial lenses- Boon to cataract patients
3. Vitamin C to put off cataract
4. Eye colour is a component in cataract
5. PUFA reduces risk of cataract
6. Cooking with unflued stove can cause cataract
7. Thyroid hormone treatment hastens recovery after cardiac surgery
8. Two doctors suspended for wrong brain surgery
9. Researchers urge caution in using ear tube surgery
10. Sweaty palms syndrome can be cured by surgery
11. Surviving surgery

Post Your Comments:
(Date:11/30/2009)...e bills stack up , , MONDAY, Nov. 30 (He...g through the U.S. Congress differ in a number of ...on in the number of uninsured Americans. , Legi...arlier this month would expand coverage to 96 perc...e a proposal to expand coverage to 94 percent of A...
(Date:11/30/2009)...about a stocking stuffer that saves lives? Holiday...tive POP BANDS® , Pet Collars and Leashes bec... fun gifts that make a difference. , ...-- How would you like to give a gift this holiday ..., ,Vedante,s super-reflective POP BANDS® made ...
(Date:11/30/2009)... uses Staten Island courtroom to recreate scene of...% responsible for client’s accident. , ...r 30, 2009 -- A Staten Island, N.Y. jury awarded a...er who was injured at a New York City construction...gen Construction Company et al (Index No. 102557/0...
(Date:11/30/2009)...d PLYMOUTH MEETING, Pa., Nov. 30 T...announced that it has signed an agreement with ECR...r its academic medical center members special pric...ch. This agreement will offer UHC members current ..., an independent nonprofit organization, is a lead...
(Date:11/30/2009)...a study revealed that beverage can pull-tabs were ... U.S. manufacturers to stay-tabs. But a study pres...cal Society of North America (RSNA) found that the...f the driving factors leading the change in bevera...nadvertent swallowing of the pull-tab and potentia...
Breaking Medicine News(10 mins):Health News:Health Reform: What's in It for You? 2Health News:Health Reform: What's in It for You? 3Health News:Fun and Fashionable Holiday Gifts that Save Lives 2Health News:Fun and Fashionable Holiday Gifts that Save Lives 3Health News:Fun and Fashionable Holiday Gifts that Save Lives 4Health News:Raphaelson & Levine Secures $1.1 Million Verdict for Victim of New York Construction Accident 2Health News:University HealthSystem Consortium and ECRI Institute(R) to Provide Enhanced Health Technology Assessment Services 2Health News:University HealthSystem Consortium and ECRI Institute(R) to Provide Enhanced Health Technology Assessment Services 3Health News:Beverage can stay-tabs pose swallowing risk 2
...chester Medical Center (URMC) announced today that... developer and philanthropist Richard T. Fields fo...largest private donation for a specific disease pr...cular dystrophy. , The new Fields Center for FSHD...
...he University of Michigan is the lead research ins...tium to study the health consequences on victims i...al Center for Disaster Mental Health Research, inc... is funded by the National Institutes of Health. ,...
...r blow to Trasylol, used to cut down on bleeding d...5 (HealthDay News) -- The U.S. Food and Drug Admin...ty of the clotting drug aprotinin (Trasylol), afte... the FDA in 1993, is typically used to limit blood...
...ME (BioMedical Enterprises, Inc.),today announced ... Medical,Director, was elected to BME,s Board of D...excelled in his leadership as,Medical Director of ...e to the BOD over this year has demonstrated,his i...
...venue, Net Income and EPS; Revenue, Net...., Oct. 25 MICROS Systems, Inc.,(Nasdaq: MCRS ),...hospitality and retail industries, today announced...rease of $42.8 million, or 24.6%, over the sam...
...s to switch the wrigglers, orientation , THURSDAY,...hard-wired into the brains of small worms called n...ed some of the creatures to make them attracted to...y are about worms and how attraction behaviors are...
Other Medicine News:Health News:New center to lead international muscular dystrophy research effort 2Health News:New center to lead international muscular dystrophy research effort 3Health News:New center to lead international muscular dystrophy research effort 4Health News:U-M to lead disaster aftermath research center 2Health News:FDA to Review Clotting Drug After Trial Suggests Death Risk 2Health News:FDA to Review Clotting Drug After Trial Suggests Death Risk 3Health News:FDA to Review Clotting Drug After Trial Suggests Death Risk 4Health News:MICROS Reports Fiscal 2008 First Quarter Results 2Health News:MICROS Reports Fiscal 2008 First Quarter Results 3Health News:MICROS Reports Fiscal 2008 First Quarter Results 4Health News:MICROS Reports Fiscal 2008 First Quarter Results 5Health News:MICROS Reports Fiscal 2008 First Quarter Results 6Health News:MICROS Reports Fiscal 2008 First Quarter Results 7Health News:Worm Study Points to Sexuality's Origins 2
(Date:11/30/2009)..., , RICHMOND, Va., Nov. 30 ...cense with sanofi-aventis U.S. for a novel epineph...ry. Under the license, sanofi-aventis U.S. shall b...ion. Intelliject will be responsible for the on-go...approval and has retained certain co-promotion rig...
(Date:11/30/2009)..., , BRIDGEWATER, N.J., Nov. 30 /PRNewswi...ay the signing of an exclusive licensing agreement...to injector for the emergency treatment of allergi...nd Canada). ,, "We are pleased to have this op... for the millions of people who are at risk of thi...
(Date:11/30/2009)..., , ATLANTA, Ge...ollege of,Direct Support (CDS), an internet-based ...naged in partnership by MC Strategies/Elsevier and...ning Center, announced today that,its second Disab...s now,available for administrators and learners to...
Breaking Medicine Technology:Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 2Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 3Sanofi-aventis U.S. and Intelliject, Inc. Sign Licensing Agreement for Novel Epinephrine Auto Injector in North America 2Sanofi-aventis U.S. and Intelliject, Inc. Sign Licensing Agreement for Novel Epinephrine Auto Injector in North America 3Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering 2Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering 3Wed Sept 16 11 AM News Conference 3A Sioux Falls Keystone Treatment Center Is National HQ to Lead 100 Locations Nationwide in Balloon Liftoff Cele 56666 1Wed Sept 16 11 AM News Conference 3A Sioux Falls Keystone Treatment Center Is National HQ to Lead 100 Locations Nationwide in Balloon Liftoff Cele 56666 2Bright Beginnings 28R 29 NeoCare 28TM 29 Value Priced Weight Gain Infant Formula Now Available Online at www pbmstore com 56662 1Bright Beginnings 28R 29 NeoCare 28TM 29 Value Priced Weight Gain Infant Formula Now Available Online at www pbmstore com 56662 2Testing Young Athletes for Heart Defects May Save Lives 56660 1Testing Young Athletes for Heart Defects May Save Lives 56660 2
...07-Preliminary results from,the immunotherapeutic ...nter show a very good safety profile for SBG. Furt...nt have been observed,among several patients that ... monoclonal antibody against neuroblastoma. , In l...report for,the 1st quarter 2007, all 24 patients h...
...ional Myeloma Workshop held in,Kos, Greece demonst...on with bortezomib, dexamethasone and lenalidomide...ractory multiple,myeloma, and as a single agent in...acroglobulinemia, NEW YORK, June 29, 2007 /PRNewsw...oday announced that 4 posters were,presented at th...
Other Medicine Technology:Biotec Pharmacon Announces Preliminary Results from the,Sloan-Kettering Clinical Study 2Biotec Pharmacon Announces Preliminary Results from the,Sloan-Kettering Clinical Study 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7
... a new level of immunodiagnostic productivity. Opt...h any laboratory automation system. No-pause loadi...e only immunoassay system with this capability. No...thout any additional setup. Continuous sample load...
... random access operation, the Elecsys 2010 System ...ories that want to maximize productivity and effic...ity and Stat capabilities of the Elecsys 1010 syst...f an aggressive laboratory testing environment. It...
Dimension RxL Max w/o HM 50/60 HZ
Modular Analytics E 170 Module
Medicine Products: